 Rooban Babyantony Nahomi
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lens, Crystalline | 20 | 2024 | 83 | 3.990 |
Why?
| | Cataract | 14 | 2024 | 212 | 2.010 |
Why?
| | Molecular Chaperones | 11 | 2022 | 181 | 1.530 |
Why?
| | Crystallins | 9 | 2024 | 29 | 1.500 |
Why?
| | Sodium Selenite | 10 | 2013 | 10 | 1.240 |
Why?
| | Lysine | 7 | 2024 | 271 | 1.200 |
Why?
| | alpha-Crystallin A Chain | 4 | 2020 | 5 | 1.060 |
Why?
| | alpha-Crystallin B Chain | 5 | 2019 | 12 | 1.050 |
Why?
| | alpha-Crystallins | 5 | 2019 | 6 | 0.940 |
Why?
| | Glaucoma | 3 | 2022 | 247 | 0.840 |
Why?
| | Glycation End Products, Advanced | 4 | 2024 | 41 | 0.780 |
Why?
| | Epithelial Cells | 5 | 2024 | 1102 | 0.770 |
Why?
| | Vitex | 5 | 2012 | 5 | 0.750 |
Why?
| | Ocular Hypertension | 2 | 2022 | 67 | 0.700 |
Why?
| | Plant Extracts | 6 | 2011 | 184 | 0.700 |
Why?
| | Presbyopia | 2 | 2023 | 11 | 0.690 |
Why?
| | Apoptosis | 5 | 2019 | 2395 | 0.600 |
Why?
| | Sirtuins | 2 | 2019 | 48 | 0.580 |
Why?
| | Sirtuin 3 | 2 | 2019 | 58 | 0.570 |
Why?
| | Acetylation | 7 | 2024 | 244 | 0.510 |
Why?
| | Transforming Growth Factor beta2 | 2 | 2018 | 26 | 0.510 |
Why?
| | Paraffin Embedding | 2 | 2024 | 31 | 0.490 |
Why?
| | Glutathione | 6 | 2020 | 364 | 0.460 |
Why?
| | Retinal Ganglion Cells | 3 | 2022 | 115 | 0.460 |
Why?
| | Oxidative Stress | 7 | 2012 | 1331 | 0.450 |
Why?
| | Epithelial-Mesenchymal Transition | 2 | 2018 | 211 | 0.450 |
Why?
| | Disease Models, Animal | 9 | 2022 | 4525 | 0.430 |
Why?
| | Phytotherapy | 4 | 2011 | 74 | 0.430 |
Why?
| | HSP27 Heat-Shock Proteins | 2 | 2015 | 9 | 0.430 |
Why?
| | Lens Capsule, Crystalline | 1 | 2024 | 10 | 0.420 |
Why?
| | Sulfhydryl Compounds | 2 | 2024 | 187 | 0.420 |
Why?
| | Formaldehyde | 1 | 2024 | 64 | 0.410 |
Why?
| | Calpain | 3 | 2010 | 61 | 0.360 |
Why?
| | Flavonoids | 3 | 2011 | 86 | 0.360 |
Why?
| | Cellular Senescence | 1 | 2024 | 223 | 0.350 |
Why?
| | Rats, Sprague-Dawley | 12 | 2015 | 2512 | 0.350 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2020 | 181 | 0.340 |
Why?
| | Thiobarbituric Acid Reactive Substances | 8 | 2012 | 28 | 0.330 |
Why?
| | Diabetic Nephropathies | 1 | 2024 | 318 | 0.320 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2018 | 48 | 0.320 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 4 | 0.320 |
Why?
| | Kynurenic Acid | 1 | 2020 | 17 | 0.320 |
Why?
| | Protein Processing, Post-Translational | 3 | 2024 | 466 | 0.310 |
Why?
| | Malonates | 1 | 2019 | 8 | 0.310 |
Why?
| | Endothelial Cells | 2 | 2018 | 862 | 0.310 |
Why?
| | Propionates | 1 | 2019 | 38 | 0.300 |
Why?
| | Chromatography, Liquid | 4 | 2024 | 444 | 0.300 |
Why?
| | Rats | 12 | 2022 | 5553 | 0.300 |
Why?
| | Peptides | 2 | 2015 | 985 | 0.290 |
Why?
| | Animals | 23 | 2023 | 37800 | 0.280 |
Why?
| | Tandem Mass Spectrometry | 4 | 2024 | 565 | 0.280 |
Why?
| | Capsule Opacification | 1 | 2018 | 18 | 0.270 |
Why?
| | Antioxidants | 6 | 2015 | 542 | 0.270 |
Why?
| | Eye Proteins | 1 | 2018 | 85 | 0.270 |
Why?
| | Retinal Degeneration | 1 | 2018 | 39 | 0.270 |
Why?
| | Superoxide Dismutase | 7 | 2012 | 300 | 0.270 |
Why?
| | Retinal Vessels | 1 | 2018 | 69 | 0.260 |
Why?
| | Triterpenes | 1 | 2007 | 25 | 0.260 |
Why?
| | Reperfusion Injury | 1 | 2020 | 295 | 0.250 |
Why?
| | Blotting, Western | 5 | 2019 | 1160 | 0.240 |
Why?
| | Catalase | 6 | 2012 | 130 | 0.240 |
Why?
| | MAP Kinase Signaling System | 1 | 2018 | 305 | 0.240 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 294 | 0.230 |
Why?
| | Diabetic Retinopathy | 1 | 2018 | 199 | 0.230 |
Why?
| | HSP20 Heat-Shock Proteins | 1 | 2015 | 1 | 0.220 |
Why?
| | Protein Aggregation, Pathological | 1 | 2015 | 21 | 0.220 |
Why?
| | Photobleaching | 1 | 2015 | 23 | 0.220 |
Why?
| | Mice, Inbred C57BL | 6 | 2023 | 5954 | 0.220 |
Why?
| | Mice, Knockout | 5 | 2020 | 3106 | 0.210 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2018 | 323 | 0.210 |
Why?
| | Mice | 9 | 2023 | 18218 | 0.210 |
Why?
| | Eye Diseases | 1 | 2015 | 93 | 0.200 |
Why?
| | Calcium-Transporting ATPases | 5 | 2011 | 33 | 0.200 |
Why?
| | Brain Diseases | 1 | 2015 | 152 | 0.200 |
Why?
| | Glycosylation | 3 | 2020 | 160 | 0.200 |
Why?
| | Organ Culture Techniques | 4 | 2019 | 149 | 0.200 |
Why?
| | Rutin | 1 | 2013 | 3 | 0.190 |
Why?
| | Reactive Oxygen Species | 5 | 2018 | 601 | 0.190 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 45 | 0.190 |
Why?
| | Heat-Shock Proteins | 3 | 2022 | 133 | 0.190 |
Why?
| | Luteolin | 1 | 2012 | 4 | 0.180 |
Why?
| | Aging | 2 | 2020 | 1935 | 0.180 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1501 | 0.170 |
Why?
| | Moringa oleifera | 1 | 2010 | 3 | 0.170 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.160 |
Why?
| | Cells, Cultured | 4 | 2024 | 4102 | 0.160 |
Why?
| | Intraocular Pressure | 2 | 2022 | 325 | 0.160 |
Why?
| | Brassica | 1 | 2010 | 5 | 0.160 |
Why?
| | Flavonols | 1 | 2010 | 26 | 0.160 |
Why?
| | Solubility | 2 | 2023 | 234 | 0.150 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2589 | 0.150 |
Why?
| | Protein Isoforms | 1 | 2011 | 393 | 0.150 |
Why?
| | Animals, Newborn | 4 | 2013 | 888 | 0.140 |
Why?
| | Lipid Peroxidation | 4 | 2010 | 160 | 0.130 |
Why?
| | Structure-Activity Relationship | 2 | 2015 | 564 | 0.130 |
Why?
| | Humans | 18 | 2024 | 144298 | 0.130 |
Why?
| | Tryptophan | 2 | 2013 | 175 | 0.120 |
Why?
| | Cattle | 2 | 2020 | 971 | 0.120 |
Why?
| | Cytokines | 1 | 2013 | 2043 | 0.120 |
Why?
| | Aged | 6 | 2024 | 25901 | 0.120 |
Why?
| | Middle Aged | 7 | 2024 | 35892 | 0.110 |
Why?
| | Cytoskeletal Proteins | 2 | 2019 | 155 | 0.110 |
Why?
| | Immunohistochemistry | 2 | 2019 | 1699 | 0.110 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 187 | 0.110 |
Why?
| | Acetyl Coenzyme A | 1 | 2024 | 7 | 0.110 |
Why?
| | Calcium | 4 | 2011 | 1174 | 0.110 |
Why?
| | Tissue Fixation | 1 | 2024 | 36 | 0.110 |
Why?
| | Protein Structure, Secondary | 2 | 2013 | 362 | 0.100 |
Why?
| | HeLa Cells | 2 | 2016 | 631 | 0.100 |
Why?
| | Injections, Intraperitoneal | 2 | 2015 | 115 | 0.100 |
Why?
| | Protein Structure, Tertiary | 2 | 2013 | 847 | 0.100 |
Why?
| | Axonal Transport | 1 | 2022 | 24 | 0.090 |
Why?
| | Disulfides | 1 | 2023 | 94 | 0.090 |
Why?
| | Interferon-gamma | 2 | 2018 | 781 | 0.090 |
Why?
| | Neuroprotection | 1 | 2022 | 45 | 0.090 |
Why?
| | Acetic Anhydrides | 1 | 2011 | 2 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2011 | 104 | 0.090 |
Why?
| | Cell Line | 2 | 2018 | 2821 | 0.090 |
Why?
| | Glutathione Peroxidase | 2 | 2012 | 39 | 0.090 |
Why?
| | Glutamine | 1 | 2011 | 108 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 159 | 0.080 |
Why?
| | Tetroses | 1 | 2020 | 2 | 0.080 |
Why?
| | gamma-Crystallins | 1 | 2020 | 2 | 0.080 |
Why?
| | Protein Denaturation | 1 | 2020 | 71 | 0.080 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 107 | 0.080 |
Why?
| | Plant Leaves | 2 | 2011 | 137 | 0.080 |
Why?
| | Water | 1 | 2023 | 465 | 0.080 |
Why?
| | Thermodynamics | 1 | 2011 | 424 | 0.070 |
Why?
| | Succinates | 1 | 2019 | 23 | 0.070 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 881 | 0.070 |
Why?
| | Cytosol | 1 | 2019 | 213 | 0.070 |
Why?
| | Gain of Function Mutation | 1 | 2019 | 34 | 0.070 |
Why?
| | Scattering, Radiation | 2 | 2015 | 99 | 0.070 |
Why?
| | Circular Dichroism | 1 | 2019 | 144 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 262 | 0.060 |
Why?
| | Proteomics | 1 | 2024 | 1182 | 0.060 |
Why?
| | Immunoblotting | 1 | 2007 | 292 | 0.060 |
Why?
| | Peptide Hydrolases | 1 | 2007 | 105 | 0.060 |
Why?
| | Snail Family Transcription Factors | 1 | 2016 | 17 | 0.060 |
Why?
| | Kidney | 1 | 2024 | 1493 | 0.060 |
Why?
| | Smad3 Protein | 1 | 2016 | 41 | 0.060 |
Why?
| | Smad2 Protein | 1 | 2016 | 36 | 0.060 |
Why?
| | Smad4 Protein | 1 | 2016 | 33 | 0.060 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1246 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 832 | 0.060 |
Why?
| | Protein Conformation | 1 | 2019 | 935 | 0.060 |
Why?
| | Free Radical Scavengers | 2 | 2010 | 82 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 762 | 0.060 |
Why?
| | Mass Spectrometry | 1 | 2019 | 741 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2007 | 1041 | 0.060 |
Why?
| | Selenious Acid | 1 | 2015 | 2 | 0.060 |
Why?
| | Fluorescence | 1 | 2015 | 153 | 0.050 |
Why?
| | Protein Binding | 1 | 2020 | 2241 | 0.050 |
Why?
| | Protein Aggregates | 1 | 2015 | 84 | 0.050 |
Why?
| | Heat-Shock Response | 1 | 2015 | 77 | 0.050 |
Why?
| | Peroxynitrous Acid | 1 | 2013 | 11 | 0.050 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2013 | 48 | 0.050 |
Why?
| | Adult | 4 | 2020 | 40408 | 0.050 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2013 | 160 | 0.050 |
Why?
| | Female | 6 | 2024 | 78137 | 0.050 |
Why?
| | Caspase 9 | 1 | 2013 | 51 | 0.050 |
Why?
| | Protein Transport | 1 | 2015 | 436 | 0.050 |
Why?
| | Cytochromes c | 1 | 2013 | 52 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2019 | 1158 | 0.050 |
Why?
| | Cricetulus | 1 | 2013 | 114 | 0.050 |
Why?
| | CHO Cells | 1 | 2013 | 165 | 0.050 |
Why?
| | Cricetinae | 1 | 2013 | 296 | 0.050 |
Why?
| | Free Radicals | 1 | 2013 | 110 | 0.050 |
Why?
| | Trace Elements | 1 | 2013 | 52 | 0.050 |
Why?
| | RNA | 1 | 2019 | 926 | 0.050 |
Why?
| | Picrates | 1 | 2012 | 5 | 0.050 |
Why?
| | Glutathione Reductase | 1 | 2012 | 24 | 0.050 |
Why?
| | Caspase 3 | 1 | 2013 | 233 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 218 | 0.040 |
Why?
| | RNA Interference | 1 | 2013 | 472 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2012 | 66 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 971 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2013 | 390 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2015 | 591 | 0.040 |
Why?
| | Protein Folding | 1 | 2013 | 277 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2015 | 446 | 0.040 |
Why?
| | Down-Regulation | 1 | 2013 | 613 | 0.040 |
Why?
| | Age Factors | 1 | 2019 | 3324 | 0.040 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 109 | 0.040 |
Why?
| | Retina | 1 | 2013 | 319 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2011 | 168 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2127 | 0.040 |
Why?
| | Amino Acids | 1 | 2015 | 518 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2013 | 503 | 0.040 |
Why?
| | Polyphenols | 1 | 2010 | 20 | 0.040 |
Why?
| | Bixaceae | 1 | 2010 | 1 | 0.040 |
Why?
| | Microscopy, Electron | 1 | 2011 | 412 | 0.040 |
Why?
| | Copper Sulfate | 1 | 2010 | 8 | 0.040 |
Why?
| | Drug Interactions | 1 | 2012 | 401 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2896 | 0.040 |
Why?
| | Quercetin | 1 | 2010 | 18 | 0.040 |
Why?
| | Hot Temperature | 1 | 2013 | 407 | 0.040 |
Why?
| | Phenols | 1 | 2010 | 107 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2012 | 0.040 |
Why?
| | Drug Combinations | 1 | 2010 | 392 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1206 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2013 | 894 | 0.040 |
Why?
| | Male | 3 | 2024 | 72263 | 0.030 |
Why?
| | Glucose | 1 | 2013 | 1033 | 0.030 |
Why?
| | Cell Membrane | 1 | 2011 | 704 | 0.030 |
Why?
| | Young Adult | 1 | 2020 | 14092 | 0.020 |
Why?
| | Signal Transduction | 1 | 2016 | 5182 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 8265 | 0.020 |
Why?
| | Adolescent | 1 | 2020 | 22370 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1607 | 0.020 |
Why?
| | Homeostasis | 1 | 2008 | 635 | 0.010 |
Why?
|
|
Babyantony Nahomi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|